https://www.selleckchem.com/pr....oducts/atglistatin.h
KRAS gene is the most common type of mutation reported in colorectal cancer (CRC). KRAS mutation-mediated regulation of immunophenotype and immune pathways in CRC remains to be elucidated. 535 CRC patients were used to compare the expression of immune-related genes (IRGs) and theabundance of tumor-infiltrating immune cells (TIICs) in the tumor microenvironment between KRAS-mutant and KRAS wild-type CRC patients. An independent dataset included 566 cases of CRC and an in-house RNA sequencing dataset wereserved as validation sets. An
Like
Comment
Share
